Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

6(66.7%)

Phase 2

1(11.1%)

Phase 4

1(11.1%)

Phase 1

1(11.1%)

9Total

N/A(6)

Phase 2(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02053649Not ApplicableCompleted

Integrated Chronotherapy for Perinatal Depression

Role: collaborator

NCT02081287Phase 1Completed

Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?

Role: collaborator

NCT01928043Phase 2Terminated

Adjunctive Curcumin for Symptomatic Adolescents With Bipolar Disorder: Brain and Body Considerations

Role: collaborator

NCT01805440Not ApplicableCompleted

Uridine Adolescent Bipolar Depression Randomized Controlled Trial

Role: collaborator

NCT01929681Not ApplicableCompleted

Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression

Role: collaborator

NCT01717040Phase 4Terminated

Pioglitazone for the Treatment of Bipolar Depression

Role: collaborator

NCT01764035Not ApplicableCompleted

Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder

Role: collaborator

NCT01520129Not ApplicableCompleted

Pilot Study of Interpersonal and Social Rhythm Therapy for Subthreshold Bipolar

Role: collaborator

NCT01625546Not ApplicableCompleted

Whole Body Hyperthermia and Major Depression (MDD)

Role: collaborator

All 9 trials loaded